Home › Genzyme Receives Complete Response Letter from FDA on Lemtradaa (alemtuzumab) Application
 

Keywords :   


Genzyme Receives Complete Response Letter from FDA on Lemtradaa (alemtuzumab) Application

2013-12-30 08:58:17| Biotech - Topix.net

Genzyme , a Sanofi company , announced today that it has received a Complete Response Letter from the U.S. Food and Drug Administration for its supplemental Biologics License Application seeking approval of Lemtrada for the treatment of relapsing forms of multiple sclerosis.

Tags: complete application response letter

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 9
05.11Tropical Storm Rafael Wind Speed Probabilities Number 9
05.11Tropical Storm Rafael Public Advisory Number 9
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 9
05.11Delayed implementation of EID eartag rule requested
More »